Cargando…

Tolerability of nintedanib in the elderly with idiopathic pulmonary fibrosis: A single-center retrospective study

Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial lung disease, predominantly affects the elderly and is associated with a high mortality risk. Nintedanib, a tyrosine kinase inhibitor, significantly reduces IPF progression. However, data on the tolerability and efficacy of nintedanib in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komatsu, Masamichi, Yamamoto, Hiroshi, Ichiyama, Takashi, Kawakami, Satoshi, Uehara, Takeshi, Yoshikawa, Yumi, Kitaguchi, Yoshiaki, Ushiki, Atsuhito, Yasuo, Masanori, Hanaoka, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812933/ https://www.ncbi.nlm.nih.gov/pubmed/35113907 http://dx.doi.org/10.1371/journal.pone.0262795

Ejemplares similares

Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study
por: Komatsu, Masamichi, et al.
Publicado: (2021)

Comparison of gene expression profiling between lung fibrotic and emphysematous tissues sampled from patients with combined pulmonary fibrosis and emphysema
por: Hanaoka, Masayuki, et al.
Publicado: (2012)

Cytokine profiles in the BAL fluid of IgG(4)-related respiratory disease compared with sarcoidosis
por: Yamamoto, Hiroshi, et al.
Publicado: (2015)

A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis
por: Ozawa, Yoko, et al.
Publicado: (2020)

Differences Between Central Airway Obstruction and Chronic Obstructive Pulmonary Disease Detected with the Forced Oscillation Technique
por: Yasuo, Masanori, et al.
Publicado: (2020)

Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study
por: Ikuyama, Yuichi, et al.
Publicado: (2020)

Successful Rescue of Life-threatening Hemoptysis Caused by Pulmonary Tuberculosis Bridging with Extracorporeal Membrane Oxygenation
por: Araki, Taisuke, et al.
Publicado: (2022)

Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia
por: Ushiki, Atsuhito, et al.
Publicado: (2014)

Bevacizumab-induced tracheoesophageal fistula in a patient suffering from lung cancer with bulky subcarinal lymph node: a case report
por: Nishie, Kenichi, et al.
Publicado: (2018)

Twenty-year Follow-up of the First Bilateral Living-donor Lobar Lung Transplantation in Japan
por: Komatsu, Masamichi, et al.
Publicado: (2019)

Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia
por: Komatsu, Masamichi, et al.
Publicado: (2022)

Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report
por: Ikuyama, Yuichi, et al.
Publicado: (2020)

Obstructive Pneumonia Associated with Endobronchial Aspergilloma: Successful Treatment with Interventional Bronchoscopy and Antifungals
por: Komatsu, Masamichi, et al.
Publicado: (2022)

Successful ventilator weaning following vascular bypass in patient with vascular tracheobronchial compression
por: Sonehara, Kei, et al.
Publicado: (2018)

Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
por: Corte, Tamera, et al.
Publicado: (2015)

Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2019)

Self-assessment of Allergic Rhinitis and Asthma (SACRA) Questionnaire-based Allergic Rhinitis Treatment Improves Asthma Control in Asthmatic Patients with Allergic Rhinitis
por: Yasuo, Masanori, et al.
Publicado: (2017)

Usual Interstitial Pneumonia Pattern Interstitial Lung Disease Developed in a Patient with IgG4-related Chronic Sclerosing Sialadenitis
por: Yamamoto, Hiroshi, et al.
Publicado: (2022)

Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation
por: Kitaguchi, Yoshiaki, et al.
Publicado: (2016)

Remarkable response of non‐small cell lung cancer to nintedanib treatment in a patient with idiopathic pulmonary fibrosis
por: Kai, Yoshiro, et al.
Publicado: (2021)

The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019()
por: Goto, Norihiko, et al.
Publicado: (2021)

Histologic factors associated with nintedanib efficacy in patients with idiopathic pulmonary fibrosis
por: Nemoto, Masahiro, et al.
Publicado: (2021)

A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT
por: Kato, Akane, et al.
Publicado: (2016)

The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
por: Kinjo, Takumi, et al.
Publicado: (2020)

Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution
por: Ichiyama, Takashi, et al.
Publicado: (2022)

Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice
por: Fletcher, Sophie V., et al.
Publicado: (2018)

Referential equations for pulmonary diffusing capacity using GAMLSS models derived from Japanese individuals with near-normal lung function
por: Wada, Yosuke, et al.
Publicado: (2022)

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
por: Wollin, Lutz, et al.
Publicado: (2015)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
por: Hajari Case, Amy, et al.
Publicado: (2017)

Diversity of respiratory impedance based on quantitative computed tomography in patients with COPD
por: Wada, Yosuke, et al.
Publicado: (2018)

Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
por: Hughes, Gareth, et al.
Publicado: (2016)

Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis
por: Takeda, Takayuki, et al.
Publicado: (2020)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2015)

Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
por: Rodríguez-Portal, José Antonio
Publicado: (2017)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
por: Ryerson, Christopher J., et al.
Publicado: (2019)

Colitis Associated with Nintedanib Therapy for Idiopathic Pulmonary Fibrosis (IPF)
por: Oda, Keishi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u8man4kneku60h4cr2rsdr91vg